Quality of life related to recombinant TSH treatment compared to no treatment related to iodine uptake, in patient with thyroid cancer. A double blinded, randomized crossover study. Dathyrca I.
Phase of Trial: Phase IV
Latest Information Update: 02 Apr 2014
At a glance
- Drugs Thyrotropin alfa (Primary) ; Liothyronine
- Indications Thyroid cancer
- Focus Diagnostic use
- Acronyms Dathyrca I
- 02 Apr 2014 Status changed from discontinued to completed.
- 03 Mar 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 23 Aug 2011 New trial record